Capturing a $12.49 Billion Opportunity in Global Pharmacovigilance and Safety Testing Services
From Labor-intensive to Digitally Enabled: The Future of Drug Safety Monitoring
Pharmaceutical companies are rapidly moving away from siloed, manual pharmacovigilance operations toward integrated partner ecosystems that combine digital tools, unified data-capture systems, and regulatory standardization. These advancements are creating a seamless, tech-enabled clinical trial and safety environment that reduces the burden on investigators and sites.
Our latest analysis shows how CROs, pharmaceutical companies, and regulatory agencies are licensing eClinical and PV platforms and selectively outsourcing services to reduce time-to-signal, meet ICSR (Individual Case Safety Report), RMP (Risk Management Plan), and PSUR (Periodic Safety Update Report) deadlines, and remain audit-ready.
Download Now
Ecosystem Snapshot
- Growth Drivers: Adverse event data explosion, regulatory pressure, tech-enabled workflows
- Companies to Watch: QVIA, ICON plc, Freyr Solutions
- Key Technologies: AI-enabled case processing, personalized patient monitoring, intelligent smart reporting and analytics
Is your PV strategy truly tech-enabled, or are outdated workflows slowing down compliance and decision-making?
Modernizing Pharmacovigilance and Safety Testing Outsourcing Services: Frost & Sullivan Has You Covered With:
- Strategies to overcome growth barriers like data transfer restrictions, lack of in-house QPPVs/LPPVs, and process inconsistencies.
- Emerging opportunities across Pharmacovigilance-as-a-Service, precision pharmacovigilance, and advanced safety monitoring services.
- Regional adoption patterns and investment priorities across North America, Europe, Asia-Pacific, MEA, and LATAM.
Discover the competitive dynamics, regional insights, technology megatrends, and strategic growth opportunities shaping the future of pharmacovigilance outsourcing.
Sign up for a complimentary Growth Pipeline Dialog™
A Growth Pipeline Dialog is a structured discussion with our growth experts providing unparalleled technology intelligence and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.
Upon completing the dialog session, you will receive a $1,000 honorarium as a token of our appreciation, which can be used towards the purchase of our products or services.
